DENNIS KWIECINSKI: Open Payments
NPI 1104439710 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,712 in 65 payments from 14 companies in 2025. Trend: 2023 $1,589 · 2024 $1,596 · 2025 $1,712
Food & beverage: $1,612Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 13 | $388 |
| Janssen Biotech, Inc. | 13 | $342 |
| Organon LLC | 4 | $176 |
| Amgen Inc. | 11 | $155 |
| ABBVIE INC. | 3 | $130 |
| Arcutis Biotherapeutics, Inc. | 2 | $116 |
| Regeneron Healthcare Solutions, Inc. | 4 | $103 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $83 |
| PFIZER INC. | 3 | $53 |
| LNHC, Inc | 1 | $45 |
Products named: OPZELURA, TREMFYA, Otezla, VTAMA, SKYRIZI, Zoryve, DUPIXENT, Cabtreo.
Industry payments across NY — which companies pay providers there.
